La Jolla Pharmaceutical Company – Strategy, SWOT and Corporate Finance Report

La Jolla Pharmaceutical Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

La Jolla Pharmaceutical Company (La Jolla) discovers, develops and commercializes biopharmaceutical products for life threatening diseases. The company’s major product includes the US FDA approved Giapreza, an injection for intravenous infusion indicated to increase blood pressure in adults with septic or other distributive shock. Its major clinical-stage investigational product candidates include LJPC-0118 for the treatment of severe malaria and LJPC-401, a proprietary formulation of synthetic human hepcidin, an endogenous peptide hormone intended for the prevention of excessive iron accumulation in vital organs. The company sells Giapreza to hospitals in the US through a network of specialty distributors. La Jolla is headquartered in San Diego, California, the US.

Scope

Detailed information on La Jolla Pharmaceutical Company required for business and competitor intelligence needs

A study of the major internal and external factors affecting La Jolla Pharmaceutical Company in the form of a SWOT analysis

An in-depth view of the business model of La Jolla Pharmaceutical Company including a breakdown and examination of key business segments

News about La Jolla Pharmaceutical Company, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of La Jolla Pharmaceutical Company and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess La Jolla Pharmaceutical Company as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on La Jolla Pharmaceutical Companys business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

PTC Therapeutics Inc

Par Pharmaceutical Inc

Lexicon Pharmaceuticals Inc

FibroGen Inc

Agios Pharmaceuticals Inc

Acceleron Pharma Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

La Jolla Pharmaceutical Company - Key Facts

La Jolla Pharmaceutical Company - Key Employees

La Jolla Pharmaceutical Company - Key Employee Biographies

La Jolla Pharmaceutical Company - Major Products and Services

La Jolla Pharmaceutical Company - History

La Jolla Pharmaceutical Company - Company Statement

La Jolla Pharmaceutical Company - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

La Jolla Pharmaceutical Company - Business Description

La Jolla Pharmaceutical Company - SWOT Analysis

SWOT Analysis - Overview

La Jolla Pharmaceutical Company - Strengths

La Jolla Pharmaceutical Company - Weaknesses

La Jolla Pharmaceutical Company - Opportunities

La Jolla Pharmaceutical Company - Threats

La Jolla Pharmaceutical Company - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

La Jolla Pharmaceutical Company, Recent Deals Summary

Section 5 Company’s Recent Developments

May 06, 2019: La Jolla Pharmaceutical Company announces financial results for the three months ended March 31, 2019 and highlights recent corporate progress

Mar 11, 2019: La Jolla Pharmaceutical names Darryl Wellinghoff as Chief Commercial Officer

Mar 04, 2019: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Highlights Recent Corporate Progress and Key Objectives

Jan 07, 2019: La Jolla Pharmaceutical Company highlights recent corporate progress and key objectives

Oct 24, 2018: La Jolla Pharmaceutical Company Reports Financial Results for the Three and Nine Months Ended September 30, 2018

Aug 08, 2018: La Jolla Pharmaceutical company announces financial results for the three and six months ended June 30, 2018 and recent corporate progress

May 10, 2018: La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress

Feb 22, 2018: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

La Jolla Pharmaceutical Company, Key Facts

La Jolla Pharmaceutical Company, Key Employees

La Jolla Pharmaceutical Company, Key Employee Biographies

La Jolla Pharmaceutical Company, Major Products and Services

La Jolla Pharmaceutical Company, History

La Jolla Pharmaceutical Company, Subsidiaries

La Jolla Pharmaceutical Company, Key Competitors

La Jolla Pharmaceutical Company, Ratios based on current share price

La Jolla Pharmaceutical Company, Annual Ratios

La Jolla Pharmaceutical Company, Annual Ratios (Cont…1)

La Jolla Pharmaceutical Company, Interim Ratios

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

La Jolla Pharmaceutical Company, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

La Jolla Pharmaceutical Company, Performance Chart (2014 – 2018)

La Jolla Pharmaceutical Company, Ratio Charts

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports